Regenerative bone scaffold as well as preparation method and application thereof

CN118924949APending Publication Date: 2024-11-12SHANGHAI UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410977372.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The biologically active ions added to the existing biological bone scaffolds are single, which does not conform to the human natural environment, and it is difficult to promote the pregeneration of vascularized networks and bone defect repair. There is no report that the timing release of multiple biologically active ions is achieved.

Method used

The composite hydrogel bone scaffold is used to coat the polyε-caprolactone layer on the surface and fill the pores with Mg2+ hydrogel microspheres. The biologic is achieved by loading Si4+ and Mg2+ hydrogel microspheres by mesoporous silica nanoparticles. The timing release of active ions promotes angiogenesis and bone defect repair.

Benefits of technology

The timing release of a variety of biologically active ions is achieved, which promotes angiogenesis and bone defect repair, improves cell migration and nutrient exchange, and significantly improves the bone defect repair effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924949A_ABST
    Figure CN118924949A_ABST
Patent Text Reader

Abstract

The invention provides a regenerated bone scaffold as well as a preparation method and application thereof, and belongs to the technical field of bone tissue engineering. Mesoporous silica particles are used in the composite hydrogel bone scaffold to load Si < 4 + >, and meanwhile, pores of the scaffold are filled with Mg < 2 + > hydrogel microspheres to load Mg < 2 + >, so that two bioactive ions Mg < 2 + > and Si < 4 + > are loaded in different modes; the surface of the bone scaffold is coated with a poly (epsilon-caprolactone) layer, so that the degradation rate of Mg2 hydrogel microspheres is superior to that of a composite hydrogel bone scaffold, sequential release of Mg < 2 + > and Si < 4 + > is formed, and angiogenesis and bone defect repair are promoted; moreover, in the subsequent stent degradation process, the degradation rate of the hydrogel material is higher than that of the poly epsilon-caprolactone, and the stent gradually forms a hollow three-dimensional transverse and longitudinal through structure only containing the poly epsilon-caprolactone, so that the exchange of nutrient substances and the migration and growth of cells are facilitated, and the generation and invasion of blood vessels are promoted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of bone tissue engineering, and in particular to a regenerative bone scaffold and a preparation method and application thereof. Background Art

[0002] The natural bone repair of the human body is a continuous process, including angiogenesis, soft callus formation, hard callus formation and mineralized bone remodeling. Currently, autologous bone transplantation and allogeneic bone transplantation are commonly used treatment methods, but they can cause complications such as infection and rejection. The 3D bioprinted bone tissue engineering scaffold has good biocompatibility and biodegradability, providing new ideas and directions for the repair of bone defects.

[0003] For the repair of large bone defects, the lack of new blood vessel growth and insufficient blood vessel supply in the early stage will lead to low activity of central tissue cells, insufficient blood supply to the repair site, affecting the delivery of oxygen and nutrients, and thus affecting the growth and development of new bone tissue. In the prior art, bioactive ions are added to biological bone scaffolds to improve angiogenesis and bone defect repair effects, but the bioactive ions added to biological bone scaffolds are single, which is not in line with the natural environment of the human body and is not conducive to promoting the pre-generation of vascularized networks and bone defect repair.

[0004] Bone homeostasis requires the regulation of multiple bioactive ions. Controlling the temporal release of multiple bioactive ions can promote the pre-generation of vascularized networks and the repair of bone defects. However, there are currently no reports on adding multiple bioactive ions to biological bone scaffolds and enabling the bioactive ions in the scaffolds to be released in a temporal manner to repair bone defects. Summary of the invention

[0005] The purpose of the present invention is to provide a regenerative bone scaffold and a preparation method and application thereof. The regenerative bone scaffold prepared by the present invention can realize the timed release of multiple bioactive ions, which is beneficial to angiogenesis and bone defect repair.

[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0007] The present invention provides a regenerative bone scaffold, comprising a composite hydrogel bone scaffold, a poly-ε-caprolactone layer coated on the surface of the composite hydrogel bone scaffold, and Mg filled in the pores of the composite hydrogel bone scaffold. 2+ Hydrogel microspheres; the composite hydrogel bone scaffold comprises a hydrogel material and mesoporous silica nanoparticles distributed in the hydrogel material.

[0008] Preferably, the hydrogel material is methacrylated gelatin or gelatin.

[0009] Preferably, the mass ratio of the hydrogel material to the mesoporous silica nanoparticles in the composite hydrogel bone scaffold is 1:(1.61-3.3).

[0010] Preferably, the poly-ε-caprolactone layer has a thickness of 50 to 180 μm.

[0011] Preferably, the Mg 2+ The diameter of the hydrogel microspheres is 170-230 μm.

[0012] The present invention also provides a method for preparing the above-mentioned regenerated bone scaffold, comprising the following steps:

[0013] (1) mixing a hydrogel material, a curing agent, mesoporous silica nanoparticles and an inorganic solvent, and then sequentially performing 3D printing and a first curing to obtain a composite hydrogel bone scaffold;

[0014] (2) immersing the composite hydrogel bone scaffold obtained in step (1) in a poly-ε-caprolactone solution to obtain a composite hydrogel bone scaffold with a surface coated with poly-ε-caprolactone;

[0015] (3) Mg 2+ The microsphere injection solution is injected into the composite hydrogel bone scaffold coated with poly-ε-caprolactone obtained in step (2) for a second curing to obtain a regenerated bone scaffold; the Mg 2+ Microsphere injection is Mg 2+ A mixture of hydrogel microspheres, methacrylated gelatin and an inorganic solvent; the Mg 2+ The hydrogel material and inorganic solvent in the microsphere injection are the same as those in step (1).

[0016] Preferably, in step (1), the mass ratio of the hydrogel material to the curing agent is (10-13): (0.2-0.26).

[0017] Preferably, the mass concentration of the poly-ε-caprolactone solution in step (2) is 25-35 wt%.

[0018] The present invention also provides the use of the above-mentioned regenerated bone scaffold in preparing a material for treating bone defects and repairing them.

[0019] The present invention provides a regenerative bone scaffold, comprising a composite hydrogel bone scaffold, a poly-ε-caprolactone layer coated on the surface of the composite hydrogel bone scaffold, and Mg filled in the pores of the composite hydrogel bone scaffold. 2+ The composite hydrogel bone scaffold comprises a hydrogel material and mesoporous silica nanoparticles distributed in the hydrogel material. The present invention uses mesoporous silica particles in the composite hydrogel bone scaffold to load Si 4+ , while filling the pores of the scaffold with Mg2+ Hydrogel microspheres loaded with Mg 2+ , so that Mg 2+ With Si 4+ The two bioactive ions were loaded in different ways; Mg 2+ The degradation rate of hydrogel microspheres is better than that of composite hydrogel bone scaffolds, forming Mg 2+ With Si 4+ The timed release promotes angiogenesis and bone defect repair; and in the subsequent scaffold degradation process, the hydrogel material degrades faster than poly-ε-caprolactone, and the scaffold gradually forms a hollow three-dimensional horizontal and vertical structure with only poly-ε-caprolactone, which is conducive to the exchange of nutrients and the migration and growth of cells, and promotes the formation and invasion of blood vessels. The results of the embodiment show that the HUVECs cell proliferation rate of the regenerated bone scaffold provided by the present invention is 128%, and the BMSCs cell proliferation rate is 163%; the number of tubular formations is 37, and the total length of branches is 3.6×103; the VEGF mRNA expression level is 4.8, the OPN mRNA expression level is 3.5, and the ALP mRNA expression level is 3.6. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 Flow chart of the composite hydrogel bone scaffold prepared in Example 1 and the composite hydrogel bone scaffold coated with poly-ε-caprolactone;

[0021] Figure 2 For the preparation of Mg in Example 1 2+ Flowchart of hydrogel microspheres;

[0022] Figure 3 This is a flow chart of preparing the regenerated bone scaffold in Example 1;

[0023] Figure 4 This is a diagram of the ion release and interaction mechanism of the regenerated bone scaffold prepared in Example 1. DETAILED DESCRIPTION

[0024] The present invention provides a regenerative bone scaffold, comprising a composite hydrogel bone scaffold, a poly-ε-caprolactone layer coated on the surface of the composite hydrogel bone scaffold, and Mg filled in the pores of the composite hydrogel bone scaffold. 2+ Hydrogel microspheres.

[0025] The regenerative bone scaffold provided by the present invention includes a composite hydrogel bone scaffold. In the present invention, the composite hydrogel bone scaffold includes a hydrogel material and mesoporous silica nanoparticles distributed in the hydrogel material. In the present invention, the mesoporous silica nanoparticles are used to load Si 4+ , later on, as the mesoporous silica particles degrade, Si 4+Slow and long-term release to promote bone repair.

[0026] In the present invention, the hydrogel material is preferably methacrylated gelatin or gelatin. The present invention limits the type of hydrogel material to make it closer to the structure and performance of natural bone tissue, which is helpful for bone regeneration; when the hydrogel material is methacrylated gelatin, the obtained regenerated bone scaffold has better biodegradability and biocompatibility, and is more conducive to cell adhesion and proliferation and the exchange and delivery of nutrients.

[0027] In the present invention, the particle size of the mesoporous silica nanoparticles is preferably 80-120 nm, more preferably 100 nm. The present invention limits the particle size of the mesoporous silica nanoparticles to ensure that the mesoporous silica nanoparticles are more fully mixed in the hydrogel material.

[0028] In the present invention, the mass ratio of the hydrogel material and the mesoporous silica nanoparticles in the composite hydrogel bone scaffold is preferably 1: (1.61-3.3), and more preferably 1: 2.16. The present invention limits the mass ratio of the hydrogel material and the mesoporous silica nanoparticles in the composite hydrogel bone scaffold to ensure that the mesoporous silica nanoparticles are more fully dispersed in the hydrogel material, and that the SiO2 nanoparticles can be slowly released for a long time during the subsequent degradation process. 4+ .

[0029] The regenerative bone scaffold provided by the present invention includes a poly-ε-caprolactone layer coated on the surface of the composite hydrogel bone scaffold. In the present invention, the degradation rate of the poly-ε-caprolactone layer is slower than that of the hydrogel material during the later degradation process. With the rapid degradation of the hydrogel material, the regenerative bone scaffold gradually forms a hollow channel structure in which only the poly-ε-caprolactone layer remains. Since the poly-ε-caprolactone layer is coated on the outer surface of the entire hydrogel scaffold, the hollow channel is a three-dimensional horizontal and vertical through structure, which is more conducive to the exchange of nutrients and the migration and growth of cells compared to the hollow channel structure with non-interconnected nodes formed by coaxial printing, and promotes the formation and invasion of blood vessels.

[0030] In the present invention, the thickness of the poly-ε-caprolactone layer is preferably 50 to 180 μm, more preferably 80 to 120 μm. The present invention limits the thickness of the poly-ε-caprolactone layer to make the regenerated bone scaffold structure more stable and the mechanical properties more excellent.

[0031] The regenerated bone scaffold provided by the present invention also includes Mg filled in the pores of the composite hydrogel bone scaffold. 2+ Hydrogel microspheres. The present invention fills the pores of the composite hydrogel bone scaffold with Mg 2+ Hydrogel microspheres, making Mg 2+With the early rapid release of hydrogel microspheres during degradation, angiogenesis is promoted, and a "bridge" is built for the migration of cells between two adjacent filaments, allowing cells to directly attach and migrate between fiber filaments, thereby promoting migration between cells and facilitating angiogenesis and bone defect repair.

[0032] In the present invention, the Mg 2+ The diameter of the hydrogel microspheres is preferably 170 to 230 μm, more preferably 200 to 220 μm. 2+ The diameter of the hydrogel microspheres can make Mg 2+ The hydrogel microspheres were more fully distributed in the composite hydrogel bone scaffold coated with poly-ε-caprolactone, and the Mg 2+ The release rate can be regulated to more fully promote angiogenesis.

[0033] The present invention uses mesoporous silica particles to load Si in the composite hydrogel bone scaffold. 4+ , while filling the pores of the scaffold with Mg 2+ Hydrogel microspheres loaded with Mg 2+ , so that Mg 2+ With Si 4+ The two bioactive ions were loaded in different ways; Mg 2+ The degradation rate of hydrogel microspheres is better than that of composite hydrogel bone scaffolds, forming Mg 2+ With Si 4+ The time-sequential release of Mg 2+ As the microspheres degrade, they are rapidly released early to promote angiogenesis; 4+ It needs to be released slowly and long-term as the mesoporous silica particles contained in the hydrogel degrade to promote bone repair; Mg 2+ With Si 4+ The sequential release can achieve the order of vascularization followed by osteogenesis, which is in line with the natural bone repair process of the human body and can promote bone defect repair more effectively and quickly. Moreover, in the subsequent scaffold degradation process, the hydrogel material degrades faster than poly-ε-caprolactone, and the scaffold gradually forms a hollow three-dimensional horizontal and vertical structure with only poly-ε-caprolactone remaining, which is beneficial to the exchange of nutrients and the migration and growth of cells, and promotes the formation and invasion of blood vessels.

[0034] The present invention also provides a method for preparing the above-mentioned regenerated bone scaffold, comprising the following steps:

[0035] (1) mixing a hydrogel material, a curing agent, mesoporous silica nanoparticles and an inorganic solvent, and then sequentially performing 3D printing and a first curing to obtain a composite hydrogel bone scaffold;

[0036] (2) immersing the composite hydrogel bone scaffold obtained in step (1) in a poly-ε-caprolactone solution to obtain a composite hydrogel bone scaffold with a surface coated with poly-ε-caprolactone;

[0037] (3) Mg 2+ The microsphere injection solution is injected into the composite hydrogel bone scaffold coated with poly-ε-caprolactone obtained in step (2) for a second curing to obtain a regenerated bone scaffold; the Mg 2+ Microsphere injection is Mg 2+ A mixture of hydrogel microspheres, hydrogel materials and inorganic solvents; the Mg 2+ The hydrogel material and inorganic solvent in the microsphere injection are the same as those in step (1).

[0038] The present invention mixes a hydrogel material, a curing agent, mesoporous silica nanoparticles and an inorganic solvent, and then sequentially performs 3D printing and a first curing to obtain a composite hydrogel bone scaffold.

[0039] In the present invention, the hydrogel material is preferably methacrylated gelatin or gelatin. The present invention limits the type of hydrogel material to make it closer to the structure and performance of natural bone tissue, which is helpful for bone regeneration.

[0040] In the present invention, when the hydrogel material is methacrylated gelatin, the curing agent is preferably a photoinitiator. In the present invention, the photoinitiator is preferably one of phenyl-2,4,6-trimethylbenzoyl lithium phosphate, 2,2'-azo (2-methyl-N-(2-hydroxyethyl) propionamide) and 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone. The present invention limits the type of photoinitiator to make the polymerization reaction of the hydrogel material more complete.

[0041] In the present invention, when the hydrogel material is gelatin, the curing agent is preferably one of microbial transglutaminase (MTGase) and bacterial cellulose (BC).

[0042] In the present invention, the mass ratio of the hydrogel material to the curing agent is preferably (10-13): (0.2-0.26), and more preferably 12: 0.25. The present invention limits the mass ratio of the hydrogel material to the curing agent to ensure a more complete polymerization reaction of the hydrogel material.

[0043] In the present invention, the mass of the mesoporous silica nanoparticles is preferably 21-33wt% of the total mass of the hydrogel, the photoinitiator and the inorganic solvent, and more preferably 25-30wt%. The present invention limits the mass of the mesoporous silica nanoparticles to ensure that the mesoporous silica nanoparticles are more fully dispersed in the hydrogel material, and that the Si can be slowly released for a long time during the subsequent degradation process. 4+ .

[0044] In the present invention, the inorganic solvent is preferably one of deionized water and phosphate buffer. The present invention limits the type of inorganic solvent to ensure that it is closer to the physiological environment of the human body. In the present invention, the composition of the phosphate buffer is preferably 1.06mM KH2PO4, 154mM NaCl, 5.60mM Na2HPO4, pH 7.3-7.5@25℃, and osmotic pressure 280-315mOsm / kg.

[0045] In the present invention, the mass ratio of the hydrogel material to the inorganic solvent is preferably (10-13): 100. The present invention limits the mass ratio of the hydrogel material to the inorganic solvent to ensure that the hydrogel material is dissolved more completely.

[0046] In the present invention, the temperature for mixing the hydrogel material, curing agent, mesoporous silica nanoparticles and inorganic solvent is preferably 36-38°C. In the present invention, the mixing of the hydrogel material, curing agent, mesoporous silica nanoparticles and inorganic solvent is preferably carried out under stirring. In the present invention, the stirring rate is preferably 400-600rpm; the stirring time is preferably 40-80min, more preferably 50-60min. The present invention limits the temperature and stirring conditions for mixing the hydrogel material, curing agent, mesoporous silica nanoparticles and inorganic solvent to ensure that the hydrogel material, curing agent, mesoporous silica nanoparticles and inorganic solvent are mixed more fully.

[0047] In the present invention, the 3D printing is preferably extrusion 3D printing. In the present invention, the inner diameter of the dispensing needle of the 3D printing is preferably 0.15-0.2 mm; the extrusion air pressure of the 3D printing is preferably 0.035-0.045 MPa; the temperature of the 3D printing is preferably 16-22°C; the temperature of the receiving platform of the 3D printing is preferably 4-6°C.

[0048] In the present invention, the number of layers of the composite hydrogel bone scaffold when 3D printing is preferably 6 to 9; the thickness of a single layer of the composite hydrogel bone scaffold when 3D printing is preferably 0.2 to 0.3 mm, and the shape of each layer of the composite hydrogel bone scaffold is preferably a "well" grid shape. The present invention limits the "well" grid shape and the number of layers so that subsequent Mg 2+ The hydrogel microspheres are more fully filled.

[0049] In the present invention, when the hydrogel material is methacrylated gelatin, the first curing is preferably ultraviolet curing. In the present invention, the wavelength of the ultraviolet curing is preferably 420 to 480 nm. In the present invention, the time of the ultraviolet curing is preferably 2 to 5 minutes. The present invention limits the wavelength and time of ultraviolet curing to ensure that a composite hydrogel bone scaffold with better stability is obtained.

[0050] In the present invention, when the hydrogel material is gelatin, the first solidification is preferably an enzymatic cross-linking method. In the present invention, transglutaminase is used to catalyze the cross-linking reaction between gelatin molecules to form a stable gel. The mass ratio of the microbial transglutaminase to gelatin is preferably 1: (7.5-13.75). After obtaining the composite hydrogel bone scaffold, the present invention immerses the composite hydrogel bone scaffold in a poly-ε-caprolactone solution to obtain a composite hydrogel bone scaffold with a surface coated with poly-ε-caprolactone.

[0051] In the present invention, the solvent of the poly-ε-caprolactone solution is preferably one of dichloromethane, toluene, tetrahydrofuran and ethyl acetate. The present invention limits the solvent type of the poly-ε-caprolactone solution to ensure that the poly-ε-caprolactone can be more fully dissolved. In the present invention, the mass concentration of the poly-ε-caprolactone solution is preferably 25 to 35wt%, more preferably 30wt%. The present invention limits the mass concentration of the poly-ε-caprolactone solution to ensure that the poly-ε-caprolactone is more fully dissolved.

[0052] In the present invention, the immersion time is preferably 8 to 15 minutes. The present invention limits the immersion time to ensure that the poly-ε-caprolactone can be more fully coated on the surface of the composite hydrogel bone scaffold.

[0053] After the impregnation is completed, the present invention preferably dries the impregnated product to obtain a composite hydrogel bone scaffold coated with poly-ε-caprolactone. The present invention has no special limitation on the drying operation, as long as the solvent can be removed.

[0054] After obtaining the composite hydrogel bone scaffold coated with poly-ε-caprolactone, the present invention further comprises: 2+ The hydrogel microsphere injection solution is injected into the composite hydrogel bone scaffold coated with poly-ε-caprolactone on the surface, and a second curing is performed to obtain a regenerated bone scaffold.

[0055] In the present invention, the Mg 2+ Microsphere injection includes Mg 2+ Hydrogel microspheres with hydrogel materials and inorganic solvents.

[0056] In the present invention, the Mg 2+The hydrogel microspheres are preferably prepared by microfluidic technology, which specifically comprises the following steps: mixing magnesium gluconate, gelatin and deionized water and pumping the mixed water into the water phase inlet of the microfluidic device as the water phase, and pumping sterile mineral oil into the oil phase inlet of the microfluidic device as the oil phase to perform O / W oil-in-water emulsification to obtain Mg gluconate. 2+ Hydrogel microspheres.

[0057] In the present invention, the mass ratio of magnesium gluconate to gelatin is preferably (0.8-2.2):1, more preferably (1.5-2):1. The present invention further regulates the mass ratio of magnesium gluconate to gelatin by limiting the mass ratio of magnesium gluconate to gelatin. 2+ Release rate during degradation.

[0058] In the present invention, the mass ratio of gelatin to deionized water is preferably (7-10):100. The present invention limits the mass ratio of gelatin to deionized water to ensure that gelatin, magnesium gluconate and deionized water are mixed more fully. In the present invention, the pumping flow rate of the water phase is preferably 1000-2000 μL / h, more preferably 1500 μL / h; the pumping flow rate of the oil phase is preferably 8-12 mL / h, more preferably 10 ml / h. The present invention limits the pumping flow rates of the water phase and the oil phase to ensure that the prepared Mg 2+ The particle size of hydrogel microspheres is more uniform and the monodispersity is better.

[0059] After the O / W oil-in-water emulsification is completed, the product of the O / W oil-in-water emulsification is preferably washed clean with anhydrous ethanol and phosphate buffered saline alternately to obtain Mg 2+ Hydrogel microspheres. In the present invention, the Mg 2+ The hydrogel microspheres are preferably stored at 2-6°C for future use.

[0060] In the present invention, the Mg 2+ The hydrogel material in the microsphere injection is preferably methacrylated gelatin. In the present invention, the Mg 2+ The hydrogel material and inorganic solvent in the microsphere injection are the same as those in step (1) and will not be described in detail here.

[0061] In the present invention, the Mg 2+ The mass ratio of the hydrogel material to the volume ratio of the inorganic solvent in the microsphere injection is preferably (10-13) g: 100 ml. The present invention limits the mass ratio of the hydrogel material to the volume ratio of the inorganic solvent to ensure that the hydrogel material is dissolved more fully.

[0062] In the present invention, the Mg 2+ Mg in microsphere injection 2+ The mass ratio of hydrogel microspheres to hydrogel materials is preferably 1: (6.6-12.5). 2+The mass ratio of hydrogel microspheres to hydrogel materials is to ensure that Mg 2+ The hydrogel microspheres are more fully dispersed in the hydrogel material.

[0063] In the present invention, the Mg 2+ The injection of the hydrogel microsphere injection solution and the second curing are preferably performed layer by layer according to the layer structure of the composite hydrogel bone scaffold coated with poly-ε-caprolactone; specifically, Mg 2+ The hydrogel microsphere injection solution is injected into a layer of a composite hydrogel bone scaffold coated with poly-ε-caprolactone to fill it and solidify it, and then the next layer is injected and solidified.

[0064] In the present invention, when the Mg 2+ When the hydrogel material in the microsphere injection is methacrylated gelatin, the second curing is preferably ultraviolet curing. In the present invention, the wavelength of ultraviolet light for ultraviolet curing is preferably 420 to 480 nm. In the present invention, the time of ultraviolet curing of each layer is independently preferably 2 to 5 minutes. The present invention limits the wavelength and time of ultraviolet curing to ensure that a regenerated bone scaffold with better stability is obtained.

[0065] In the present invention, the number of times of deionized water washing is preferably 2 to 3 times. In the present invention, the freezing temperature is preferably -78 to 82°C; the freezing time is preferably 8 to 10 hours. In the present invention, the freeze-drying time is preferably 8 to 10 hours.

[0066] The present invention obtains a composite hydrogel bone scaffold by mixing a hydrogel material, a curing agent, mesoporous silica nanoparticles and an inorganic solvent, and then sequentially performing 3D printing and curing. In the subsequent scaffold degradation process, the mesoporous silica nanoparticles can slowly degrade with the hydrogel, and release Si for a long time. 4+ , promoting bone repair; then the composite hydrogel bone scaffold is immersed in a poly-ε-caprolactone solution to obtain a composite hydrogel bone scaffold with a surface coated with poly-ε-caprolactone. In the subsequent scaffold degradation process, the hydrogel is degraded faster than poly-ε-caprolactone, and the scaffold gradually forms a hollow three-dimensional horizontal and vertical structure with only poly-ε-caprolactone remaining, which is beneficial to the exchange of nutrients and the migration and growth of cells, and promotes the formation and invasion of blood vessels; finally, Mg 2+ The hydrogel microspheres were injected into the composite hydrogel bone scaffold coated with poly-ε-caprolactone and then photocured to obtain the regenerated bone scaffold. During the subsequent scaffold degradation process, Mg 2+ The hydrogel microspheres are rapidly released early during degradation to promote angiogenesis; and Mg is filled in the pores of the scaffold. 2+ Hydrogel microspheres build a "bridge" for the migration between cells, promote the migration between cells, and are beneficial to angiogenesis and bone defect repair.

[0067] The present invention also provides the use of the above-mentioned regenerated bone scaffold in preparing a material for treating bone defects and repairing them.

[0068] The regenerative bone scaffold provided by the present invention is applied to the treatment of bone defect repair materials to achieve Mg 2+ and Si 4+ The timed release is beneficial to angiogenesis and bone defect repair.

[0069] The technical solutions in the present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0070] Example 1

[0071] A regenerative bone scaffold, comprising a composite hydrogel bone scaffold, a poly-ε-caprolactone layer with a thickness of 100 μm coated on the surface of the composite hydrogel bone scaffold, and Mg with a diameter of 200 μm filled in the pores of the composite hydrogel bone scaffold. 2+ The composite hydrogel bone scaffold is composed of methacrylated gelatin and mesoporous silica nanoparticles with a particle size of 100 nm distributed in the methacrylated gelatin.

[0072] The preparation method of the above-mentioned regenerated bone scaffold consists of the following steps:

[0073] (1) Mix methacryloyl gelatin, phenyl-2,4,6-trimethylbenzoyl lithium phosphite and phosphate buffered saline at 37°C (eg Figure 1 A), then add mesoporous silica nanoparticles and stir at 500 rpm for 60 min (as shown in Figure 1 B), a dispensing needle with an inner diameter of 0.18 mm, an extrusion pressure of 0.04 MPa, a nozzle temperature of 19 ° C, and a platform receiving temperature of 4 ° C were used for 3D printing (as shown in FIG. Figure 1 C), and then placed under 450nm ultraviolet light for 4min for photo-crosslinking and curing to obtain 8 layers of "well" shaped composite hydrogel bone scaffolds; the thickness of each layer of the "well" shaped composite hydrogel bone scaffold is 0.3mm;

[0074] The mass ratio of the methacryloyl gelatin to the phosphate buffer is 11:100; the mass ratio of the methacryloyl gelatin to phenyl-2,4,6-trimethylbenzoyl lithium phosphite is 11:0.23; the mass of the mesoporous silica nanoparticles is 28wt% of the total mass of the methacryloyl gelatin, phenyl-2,4,6-trimethylbenzoyl lithium phosphite and phosphate buffered saline; the composition of the phosphate buffer (purchased from Servicebio, item number: G4250-500ML) is: 1.06mM KH2PO4, 154mM NaCl, 5.60mM Na2HPO4, pH 7.3-7.5@25°C, osmotic pressure 280-315mOsm / kg;

[0075] (2) According to Figure 1 As shown in D, the composite hydrogel bone scaffold obtained in the step (1) is immersed in a poly-ε-caprolactone solution with a mass concentration of 30wt% for 10 minutes, and placed in a fume hood until the solvent evaporates to obtain a composite hydrogel bone scaffold with a surface coated with poly-ε-caprolactone; the solvent of the poly-ε-caprolactone solution is dichloromethane;

[0076] (3) Figure 3 As shown in A~B, Mg 2+ The microsphere injection solution is injected into the composite hydrogel bone scaffold coated with poly ε-caprolactone obtained in step (2) with a 0.26 mm needle syringe. When each layer of the composite hydrogel bone scaffold coated with poly ε-caprolactone is filled, 450 nm ultraviolet light is used for 5 min to perform photocuring until the surface of the composite hydrogel bone scaffold coated with poly ε-caprolactone is formed. The scaffold is then rinsed with deionized water for 3 times, placed in a refrigerator at -80°C for 8 hours, and then placed in a freeze dryer for freeze drying for 8 hours to obtain a regenerated bone scaffold. The Mg 2+ Microsphere injection is Mg 2+ A mixture of hydrogel microspheres, methacrylic gelatin and deionized water; the mass ratio of the methacrylic gelatin to the volume of deionized water is 11g:100ml; the Mg 2+ The mass ratio of hydrogel microspheres to methacrylated gelatin is 1:10; the Mg 2+ Hydrogel microspheres were prepared using microfluidics technology: Figure 2 As shown in A to C, the method specifically comprises the following steps: a mixture of magnesium gluconate, gelatin and deionized water is used as the aqueous phase and pumped into the aqueous phase inlet of the microfluidic device at 1480 μL / h, and a sterile mineral oil is used as the oil phase and pumped into the oil phase inlet of the microfluidic device at 10 mL / h, and O / W oil-in-water emulsification is performed in sequence, and then anhydrous ethanol and phosphate buffered saline are used to alternately clean the mixture to obtain Mg gluconate. 2+The hydrogel microspheres are stored at 4° C. for future use; the mass ratio of the magnesium gluconate to gelatin is preferably 2:1; the mass ratio of the gelatin to deionized water is preferably 8:100.

[0077] Figure 4 Figure 1 is a diagram of the ion release and interaction mechanism of the regenerated bone scaffold prepared in Example 1. As shown in the figure: Mg 2+ With Si 4+ The sequential release of TNF-α promotes angiogenesis and bone defect repair.

[0078] Comparative Example 1

[0079] The difference between this comparative example and Example 1 is that step (2) is omitted, and the rest is the same as Example 1.

[0080] Comparative Example 2

[0081] The difference between this comparative example and Example 1 is that: the Mg in step (3) is 2+ Hydrogel microsphere injection was replaced by Mg 2 + Injection, the Mg 2+ The composition of the injection is: methacryloyl gelatin, magnesium gluconate, and phosphate buffer; the rest is the same as in Example 1.

[0082] The compressive strength of the regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1-2 was tested using a universal mechanical testing machine with a crosshead at a rate of 5 mm / min; the results are shown in Table 1.

[0083] By performing live and dead cell staining and CCK-8 experiments on human umbilical vein endothelial cells HUVECs and bone marrow mesenchymal stem cells BMSCs, the viability and proliferation capacity of the regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1 to 2 on the third day and the first day were evaluated. The results are shown in Table 1.

[0084] The vascularization process of the human umbilical vein endothelial cells HUVECs of the regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1 to 2 was evaluated by tubular formation test and total branch length test; the angiogenesis ability of the regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1 to 2 was evaluated by detecting the expression level of the angiogenesis gene vascular endothelial growth factor (VEGF) using real-time quantitative polymerase chain reaction (RT-qPCR), and the results are shown in Table 1;

[0085] The regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1 to 2 were subjected to ALP staining and ALP quantitative determination to evaluate the vitality and proliferation ability of bone marrow mesenchymal stem cells BMSCs; the regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1 to 2 were subjected to ARS staining, and the expression levels of osteogenic genes osteopontin (OPN) and alkaline phosphatase (ALP) were detected by real-time quantitative polymerase chain reaction (RT-qPCR) to evaluate the osteogenic differentiation of the three regenerated bone scaffolds. The results are shown in Table 1.

[0086] Table 1 Performance test data of the regenerated bone scaffolds prepared in Example 1 and Comparative Examples 1-2

[0087]

[0088]

[0089] It can be seen from Table 1 that: Compressive strength: Compared with the regenerated bone scaffold prepared in Example 1, the comparative example 1 is not coated with poly-ε-caprolactone, and the gap of the comparative example 2 is composed of Mg 2+ Injection solution replaces Mg 2+ Due to the filling of hydrogel microspheres, the regenerated bone scaffolds prepared in Comparative Examples 1 and 2 have lower compressive strength.

[0090] Cell proliferation rate: The proliferation rates of HUVECs and BMSCs in the regenerated bone scaffolds prepared in Example 1 were the highest, followed by Comparative Example 2, and the lowest in Comparative Example 1. The reason may be that during the degradation of the regenerated bone scaffolds in Example 1 and Comparative Example 2, hollow channels running horizontally and vertically were gradually formed, which were conducive to cell adhesion and proliferation as well as the invasion of new blood vessels.

[0091] Vascularization: Compared with the regenerated bone scaffold prepared in comparative example 1, due to the presence of the poly-ε-caprolactone layer, hollow channels can be gradually formed during the degradation of the regenerated bone scaffold in Example 1, promoting cell adhesion, nutrient delivery and blood vessel growth; compared with the regenerated bone scaffold prepared in comparative example 2, the gaps in the scaffolds in Example 1 are filled with Mg 2+ Hydrogel microspheres promote cell adhesion and migration between fibers.

[0092] Osteogenic differentiation: The regenerated bone scaffold prepared in Example 1 gradually forms a hollow channel running horizontally and vertically during the degradation process, and more new blood vessels grow into it, which promotes cell migration and the exchange of nutrients and accelerates the repair of bone defects. At the same time, due to the degradation of different parts of the scaffold structure, the regenerated bone scaffold prepared in Example 1 can release Mg sequentially. 2+ and Si 4+ ,Mg 2+ In the early rapid release, Si 4+ Slow and long-term release can simulate the characteristics of blood vessel formation before bone formation in the human body's bone defect repair process.

[0093] It can be seen that the regenerated bone scaffold prepared in Example 1 of the present invention can release Mg in a time sequence. 2+ and Si 4+ During the degradation process of the regenerated bone scaffold, a hollow channel structure with horizontal and vertical connections is gradually formed, which can accelerate the repair effect of bone defects.

[0094] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A regenerative bone scaffold comprising a composite hydrogel bone scaffold, a poly-ε-caprolactone layer coated on the surface of the composite hydrogel bone scaffold, and Mg filled in the pores of the composite hydrogel bone scaffold. 2+ Hydrogel microspheres; the composite hydrogel bone scaffold comprises a hydrogel material and mesoporous silica nanoparticles distributed in the hydrogel material.

2. The bone regeneration scaffold according to claim 1, characterized in that: The hydrogel material is methacrylated gelatin or gelatin.

3. The regenerative bone scaffold according to claim 1 or 2, characterized in that: The mass ratio of the hydrogel material to the mesoporous silica nanoparticles in the composite hydrogel bone scaffold is 1:(1.61-3.3).

4. The method for preparing a regenerative bone scaffold according to claim 1, characterized in that: The thickness of the poly-ε-caprolactone layer is 50 to 180 μm.

5. The bone regeneration scaffold according to claim 1, characterized in that: The Mg 2+ The diameter of the hydrogel microspheres is 170-230 μm.

6. The method for preparing the regenerated bone scaffold according to any one of claims 1 to 5, comprising the following steps: (1) mixing a hydrogel material, a curing agent, mesoporous silica nanoparticles and an inorganic solvent, and then sequentially performing 3D printing and a first curing to obtain a composite hydrogel bone scaffold; (2) immersing the composite hydrogel bone scaffold obtained in step (1) in a poly-ε-caprolactone solution to obtain a composite hydrogel bone scaffold with a surface coated with poly-ε-caprolactone; (3) Mg 2+ The microsphere injection solution is injected into the composite hydrogel bone scaffold coated with poly-ε-caprolactone obtained in step (2) for a second curing to obtain a regenerated bone scaffold; the Mg 2+ Microsphere injection is Mg 2+ A mixture of hydrogel microspheres, methacrylated gelatin and an inorganic solvent; the Mg 2+ The hydrogel material and inorganic solvent in the microsphere injection are the same as those in step (1).

7. The preparation method according to claim 6, characterized in that: In the step (1), the mass ratio of the hydrogel material to the curing agent is (10-13): (0.2-0.26).

8. The preparation method according to claim 6, characterized in that: The mass concentration of the poly-ε-caprolactone solution in step (2) is 25-35 wt%.

9. Use of the regenerated bone scaffold according to any one of claims 1 to 5 or the regenerated bone scaffold prepared by the preparation method according to any one of claims 6 to 8 in preparing materials for treating bone defects and repairing them.

Citation Information

Cited By

  • Hydrogel-filled polycaprolactone composite scaffold as well as preparation method and application thereof

    CN119770727A

  • Polycaprolactone stent filled with drug-loaded polydopamine hydrogel as well as preparation method and application of polycaprolactone stent

    CN119770730A